Greg Winter

Sir Gregory Paul Winter (born 14 April 1951) is a British biochemist. He is best known for his work on the therapeutic use of monoclonal antibodies. He invented techniques to both humanise (1986) and, later, to fully humanise using phage display, antibodies for therapeutic uses.[5]

Sir Greg Winter

Greg Winter EM1B5921 (31295405977).jpg
Gregory Winter in December 2018
Born (1951-04-14) 14 April 1951 (age 73)[1]
EducationRoyal Grammar School, Newcastle upon Tyne
Alma materUniversity of Cambridge (MA, PhD)
Known for
Awards
Scientific career
FieldsBiochemistry
Institutions
ThesisThe amino acid sequence of tryptophanyl tRNA synthetase from Bacillus stearothermophilus (1977)
Websitetrin.cam.ac.uk/about/master-fellows/master/winter/

Winter won the 2018 Nobel Prize in Chemistry along with George P. Smith and Frances Arnold.[6]

References

  1. WINTER, Sir Gregory (Paul). ukwhoswho.com. Who's Who. Vol. 2016 (online Oxford University Press ed.). A & C Black, an imprint of Bloomsbury Publishing plc.   (subscription needed)
  2. "EMBO MEMBER: Gregory P. Winter". people.embo.org.
  3. "Announcement of the Prince Mahidol Award 2016". princemahidolaward.org. Archived from the original on 2017-11-14. Retrieved 13 June 2017.
  4. Nobel Prize in Chemistry 2018 - live. 3 October 2018. https://www.theguardian.com/science/live/2018/oct/03/nobel-prize-in-chemistry-2018-live. Retrieved 3 October 2018. 
  5. McCafferty, J.; Griffiths, A.; Winter, G.; Chiswell, D. (1990). "Phage antibodies: filamentous phage displaying antibody variable domains". Nature. 348 (6301): 552–554. Bibcode:1990Natur.348..552M. doi:10.1038/348552a0. PMID 2247164. S2CID 4258014.
  6. "Live blog: direction evolution takes chemistry Nobel prize". Retrieved 3 October 2018.